Effects of Physical Therapy With Neuromuscular Electrical Stimulation in Critically Ill Patients: a Randomised Crossover Clinical Trial Protocol.
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Critical Care
- Sponsor
- University of Sao Paulo
- Enrollment
- 31
- Locations
- 1
- Primary Endpoint
- Change of Oxygen consumption (VO2),from baseline and interventions.
- Status
- Suspended
- Last Updated
- 5 years ago
Overview
Brief Summary
The study will investigate the effects of neuromuscular electrical stimulation (NMES) in critically ill patients. The objective of this study will be investigate the effects of neuromuscular electrical stimulation (NMES) in critically ill patients.
Detailed Description
The study will investigate the effects of neuromuscular electrical stimulation (NMES) in critically ill patients. It will be a randomised crossover clinical trial. Thirty-one patients will enrolled. Patients will be selected, randomly, to the intervention Protocol (decubitus position with the limbs raised and NMES) and control (decubitus position with the limbs raised without NMES).The patients will be allocated in Group 1 (intervention and control) or group 2 (control and intervention) with a wash-out period of 4 to 6 hours between them. The main outcome will be metabolic data. Linear mixed model will be used for analysis of dependent variables and estimated values of the mean of the differences of each effect. The results of this study will allow better understanding of the metabolic effects of NMES in patients critically ill.
Investigators
Ada Clarice Gastaldi
Principal Investigator
University of Sao Paulo
Eligibility Criteria
Inclusion Criteria
- •All patients that will be admitted to the intensive care unit
- •Hemodynamic stability
- •Mechanical ventilation.
Exclusion Criteria
- •In general:
- •a. Pregnant women
- •b. Brain death
- •c. Neuromuscular diseases
- •d. Use of pre-existing neuromuscular blocker in the last 24 hours, prior to the study protocol.
- •Contraindications for the use of NMES:
- •a. Fractures
- •c. Skin lesions
- •d. Systemic vascular impairment diseases such as systemic lupus erythematosus, thromboembolic disease, deep vein thrombosis (which was not therapeutically anticoagulated for a time greater than 36 hours)
- •e. Lower limb amputations
Outcomes
Primary Outcomes
Change of Oxygen consumption (VO2),from baseline and interventions.
Time Frame: VO2 will be taken during the each intervention, it will be taken only the first day
Change of Oxygen consumption (VO2) will be evaluated by calorimetry
Secondary Outcomes
- Change of Carbon dioxide production (VCO2) from baseline and interventions.(VCO2 will be taken during the each intervention, it will be taken only the first day)